Orion Holdings Establishes Subsidiary Orion Biologics
[Asia Economy Reporter Hwang Yoon-joo] Orion Holdings is establishing 'Orion Biologics' to strengthen its bio business.
Orion Holdings announced on the 15th that it decided at the board meeting to establish Orion Biologics and incorporate it as a subsidiary on the 16th of next month.
The main business areas of Orion Biologics are the development and sales of pharmaceuticals and food ingredients. Orion Holdings plans to pay a total of 9.9 billion KRW through a capital increase.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
With the addition of Orion Biologics, the number of subsidiaries under Orion Holdings will increase to four in total.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
